Tumor-secreted IFNβ binds to the IFNAR1/2 receptors on antigen-presenting cells and tumor cells, inducing the release of proinflammatory chemokines, such as CCL5 and CXCL10 28. This evidence concerns the gene CCL5 and neoplasm.